News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2018 Shelley Wood October 02, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2018 Caitlin E. Cox September 04, 2018
News Conference News The Structural Heart Disease Summit 2018 Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms Michael O'Riordan June 27, 2018
News Conference News The Structural Heart Disease Summit 2018 SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications Michael O'Riordan June 23, 2018
News Daily News Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis Caitlin E. Cox June 11, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Daily News TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher L.A. McKeown May 11, 2018
News Daily News Recent Stroke Heightens Risk of Perioperative Events After AVR Todd Neale April 25, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2018 Shelley Wood March 01, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017